Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
SYNBIOTIC SE is a leading European corporate group operating in the dynamic environment of the industrial hemp and cannabis market.
As a public listed company, SYNBIOTIC SE offers its investors the exceptional opportunity to fully capitalise on the potential of this rapidly growing market.
Our holding strategically invests in promising ventures within the industrial hemp, medical, and recreational cannabis sectors.
In doing so, we create profitable synergies across the entire value chain. Our expertise encompasses the entire process from cultivation and research to development, production, sales, and distribution of premium industrial hemp and cannabis products.
A special feature of SYNBIOTIC SE is the rigorous quality management throughout the entire production processes and supply chain, both fully covered by majority holdings. A unique selling point in the industry.
Due to our successful buy-and-build strategy, we continuously expand ourproduction and value chain, setting new standards in the industry.
SYNBIOTIC - Your Smartest Way to Invest in Cannabis.
joined our Platform
to fulfill our Vision
We unlock the power of cannabinoids to heal modern world diseases.
Annual General Meeting on August 05, 2021.
The Annual General Meeting of SynBiotic SE took place on Thursday, August 5, 2021, at 10:00 a.m. (CEST).
The Company's Annual General Meeting was held as a virtual general meeting without the physical presence of shareholders or their proxies (except for the Company's proxies).
Additional to Top 9:
There were no countermotions.
18. November 2020: Extraordinary General Meeting
The Extraordinary General Meeting of SynBiotic SE took place on Wednesday, November 18, 2020, at 12:00 noon ( CET).
November 2024: Handelsregister B of the Düsseldorf Local Court - SYNBIOTIC SE
November 2024: Company agreement - Satzung - SYNBIOTIC SE
August 2024: Group Planning 2024-2026 EN
July 2024: Financial calendar 2024 -Update
May 2024: Data sheet Düsseldorf Stock Exchange
May 2024: Financial calendar 2024 -Update
March 2024: Basic Information Sheet of the Convertible Bond March 2024
March 2024: Convertible Bond Conditions of the Convertible Bond March 2024/2025
Exercise declaration convertible bond: August 2023/2025 (ISIN DE000A351VJ4)
December 2023: Financial calendar 2024
August 2023: Securities Information Sheet- Update as of 25 August 2023
August 2023: Securities Information Sheet dated 20 August 2023
August 2023: Basic Information Sheet of the Convertible Bond August 2023/2025
August 2023: Convertible Bond Conditions of the Convertible Bond August 2023/2025
October 2021: Securities Information Sheet pursuant to § 4 of the German Securities Prospectus Act ("WpPG")
December 2020: Securities Prospectus
Meet us at the investor events.
SynBiotic appears cautiously valued
SynBiotic appears cautiously valued
When time meets opportunity; initiate with a BUY
SynBiotic appears cautiously valued
Strong founder and owner network that has proven how to scale a platformcompany